When was Phase Focus founded?

Phase Focus was founded in 2006 and raised its 1st funding round 2 years after it was founded.

Where is Phase Focus located?

Phase Focus is headquartered in Sheffield, United Kingdom.

Who is the current CEO of Phase Focus?

Martin Humphry of Phase Focus. They are also an angel investors in 1 startup.

Which legal entities is Phase Focus associated with?

Phase Focus is associated with PHASEFOCUS HOLDINGS LIMITED and 1 other.

How many employees does Phase Focus have?

As of May 31, 2026, the latest employee count at Phase Focus is 6.

Is Phase Focus a funded company?

Phase Focus is a funded company, having raised a total of $12.1M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 14, 2008.

When was the latest funding round of Phase Focus?

Phase Focus' latest funding was a $***** Series B round on Aug 22, 2023, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United Kingdom, the Life Sciences Platforms and Tools sector has seen $124M in funding in 2026 to date.

Where does Phase Focus rank among its competitors?

Phase Focus ranks 50th amongst 343 active competitors, of which 65 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Nearfield Instruments, which secured $380M in Jun, 2026.

Who are the top competitors of Phase Focus?

Phase Focus' top competitors include Oxford Instruments, Olympus and FEI Company. Among them, Nearfield Instruments secured the most recent funding round in June, 2026.

Phase Focus - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Phase Focus an acquired company?

Phase Focus got acquired by Bruker on Dec 22, 2023.

Company Details

Provider of virtual lens that generates High definition images without high-quality lenses. It develops a lensless imaging method. It also finds analytical applications in life sciences and engineering metrology and in multiple wavelength regimes like visible light, X-ray, electron, and others.

Website: www.phasefocus.com/
Social

Key Metrics

Founded Year

2006

Location

Sheffield, United Kingdom

Stage

Acquired

Total Funding

$12.1M in 4 rounds

Latest Funding Round

Series B, Aug 22, 2023, $*****

Investors

Braveheart Investment Group & 12 more

Ranked

50^th among 343 active competitors

Employee Count

6 as on May 31, 2026

Similar Companies

Olympus & 325 more

Exit Details

Acquired by Bruker (Dec 22, 2023)

View Phase Focus' full profile

Phase Focus is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PHASEFOCUS HOLDINGS LIMITED CIN: 11859836 , United Kingdom, Active		-	3 (As on Dec 31, 2024)
Phase Focus Limited CIN: 5856137 , Germany, Active	Jun 22, 2006	-	10 (As on Dec 31, 2021)

Phase Focus got acquired by Bruker on Dec 22, 2023 at an acquisition amount of $*****.

Click here to take a look at Phase Focus's acquisition in detail

Phase Focus has raised a total funding of $12.1M over 4 rounds. Its first funding round was on Feb 14, 2008. Its latest funding round was a Series B round on Aug 22, 2023 for $*****. 1 investor participated in its latest round. Phase Focus has 9 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Phase Focus:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 22, 2023	3929553	Series B	9830841	9322443	3659783	6635525
Jul 03, 2012	7295292	Series B	9607947	8719548	4385252	Ombu Group & 1 more
Jul 17, 2009	1663548	Series A	9756055	6337949	9483458	South Yorkshire Investment Fund & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Phase Focus's funding rounds and investors

Here are the details of Phase Focus' key team members:

Martin Humphry: CEO of Phase Focus. They are also an angel investor in 1 startup and serve on the board of 1 company.

Phase Focus' Board of Directors

Phase Focus's board has 3 active members. Martin Humphry is part of team and Paul Atherton and Ben Edwards are independent board members.

Here is the list of Phase Focus' board of directors:

Name	Type	Representing	Status	Duration
eslfpjm	Team	-	Current	3y 3m
Paul Atherton	Independent board member	-	Current	12y 8m
geabxph	Independent board member	-	Current	5y 9m
lpzvfol	Independent board member	-	Past	3y 4m
nwbbxxj	Independent board member	-	Past	4y 7m
bsfdurq	Independent board member	-	Past	4y 2m
um{iyec	Independent board member	-	Past	6y 4m
q{wybui	Independent board member	-	Past	4y 9m
jrczca{	Independent board member	-	Past	1y 2m
sf{rqsy	Independent board member	-	Past	8y 6m
gzeyggj	Independent board member	-	Past	3y 5m
qdwnyiq	Independent board member	-	Past	7y 4m

View details of Phase Focus's Founder profiles and Board Members

Phase Focus' employee count trend

Phase Focus has 6 employees as of May 26. Here is Phase Focus's employee count trend over the years:

Uncover Phase Focus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Phase Focus include Oxford Instruments, Olympus and FEI Company. Here is the list of Top 10 competitors of Phase Focus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oxford Instruments 1959, High Wycombe (United Kingdom), Public	Manufacturer of scientific technology for atomic and molecular level research	-	Europa	69/100
2nd	Olympus 1919, Tokyo (Japan), Public	Manufacturer of imaging and surgical products	-	ValueAct Capital, Sony	67/100
3rd	FEI Company 1971, Hillsboro (United States), Acquired	Electron microscopy solutions for advancing scientific discovery and industrial innovation	$300K	Reference Capital Management, Starboard Capital Partners ... & 2 others	64/100
4th	Scholar Rock 2012, Cambridge (United States), Public	Developer of Antibody-based drugs for the treatment of primary myopathies	$103M	Fidelity Investments, Invus & 10 others	61/100
5th	M Squared 2006, Glasgow (United Kingdom), Series B	Developer of light-sheet microscopy systems for multiple business verticals	$30.7M	BGF, Barclays & 9 others	60/100
6th	NanoImaging Services 2007, San Diego (United States), Series A	Provider of cryo-electron microscopy, protein production, and nanoparticle characterization services	$13.7M	merckcapitalventures.com, Ampersand Capital ... & 3 others	59/100
7th	Leica Microsystems 1914, Wetzlar (Germany), Acquired	Manufacturer of microscopes, microscope software, cameras, parts, and accessories	-	SV Health Investors, Westlake Ventures & 1 others	59/100
8th	Nearfield Instruments 2016, Rotterdam (Netherlands), Series D	Developer of electron microscopes for 3D metrology	$549M	Fidelity Investments, Temasek & 7 others	59/100
9th	Lucida Medical 2019, Cambridge (United Kingdom), Series A	Developer of MRI-based cancer screening technology using artificial intelligence (AI)	$11.5M	prostate-cancer-research.org.uk, IW Capital ... & 20 others	58/100
10th	SamanTree Medical 2014, Lausanne (Switzerland), Series C	Developer of digital microscopy system for high-resolution imaging of tissue	$57.5M	European Investment Bank, Panakes Partners ... & 13 others	58/100
50th	Phase Focus 2006, Sheffield (United Kingdom), Acquired	Provider of virtual lens that generates High definition images without high-quality lenses	$12.1M	Ombu Group, Sussex Place Ventures & 11 others	43/100